Zobrazeno 1 - 10 of 404 pro vyhledávání: '"Rageot D"'
1
Akademický článek
The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes.
Autor: Rouland A; Department of Endocrinology, Diabetology and Nutrition, Dijon Bourgogne University Hospital, 21000 Dijon, France.; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France., Gautier T; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France., Denimal D; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.; Department of Clinical Biochemistry, Dijon Bourgogne University Hospital, 21000 Dijon, France., Duvillard L; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.; Department of Clinical Biochemistry, Dijon Bourgogne University Hospital, 21000 Dijon, France., Simoneau I; Department of Endocrinology, Diabetology and Nutrition, Dijon Bourgogne University Hospital, 21000 Dijon, France., Rageot D; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France., Vergès B; Department of Endocrinology, Diabetology and Nutrition, Dijon Bourgogne University Hospital, 21000 Dijon, France.; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France., Bouillet B; Department of Endocrinology, Diabetology and Nutrition, Dijon Bourgogne University Hospital, 21000 Dijon, France.; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.
Publikováno v: Metabolites [Metabolites] 2024 Sep 07; Vol. 14 (9). Date of Electronic Publication: 2024 Sep 07.
Zobrazit plný text záznamu
2
Akademický článek
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC.
Autor: Roussot N; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Thibaudin M; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Fumet JD; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Daumoine S; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Hampe L; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Rébé C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Limagne E; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Lagrange A; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Herreros V; Department of Interventional Radiology, Centre Georges-François Leclerc, Dijon, France., Lecuelle J; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Mananet H; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Ilie A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Rageot D; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Boidot R; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Goussot V; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Comte A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Jacob P; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Beltjens F; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Bergeron A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Charon-Barra C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Arnould L; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Derangère V; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Ladoire S; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Truntzer C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Ghiringhelli F; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Aug 07; Vol. 15, pp. 1437961. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts.
Autor: Lecuelle J; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France., Truntzer C; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France., Basile D; Department of Medical Oncology, San Giovanni di Dio Hospital, Crotone, Italy., Laghi L; Department of Medicine and Surgery, University of Parma, Parma, Italy; Molecular Gastroenterology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Greco L; Molecular Gastroenterology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Ilie A; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France., Rageot D; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France., Emile JF; Paris-Saclay University, Versailles SQY University (UVSQ), EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne, France., Bibeau F; Service d'Anatomie et Cytologie Pathologiques, CHU Côte de Nacre, Normandie Université, Caen, France; Department of Pathology, Besançon University Hospital, Besançon, France., Taïeb J; Institut du Cancer Paris Cancer Research for Personalized Medicine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France; Centre de Recherche des Cordeliers, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique, Sorbonne Université, Université Sorbonne Paris Cité, Université de Paris, Paris, France; Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP Centre, Université Paris Cité, Paris, France., Derangere V; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France; University of Burgundy Franche-Comté, Dijon, France., Lepage C; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; University of Burgundy Franche-Comté, Dijon, France; Fédération Francophone de Cancérologie Digestive, Centre de Randomisation Gestion Analyse, EPICAD LNC 1231, Dijon, France; Service d'Hépato-gastroentérologie et Oncologie digestive, CHU de Dijon, France., Ghiringhelli F; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France; University of Burgundy Franche-Comté, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. Electronic address: fghiringhelli@cgfl.fr.
Publikováno v: EBioMedicine [EBioMedicine] 2024 Jul; Vol. 105, pp. 105207. Date of Electronic Publication: 2024 Jun 15.
Zobrazit plný text záznamu
4
Akademický článek
CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy.
Autor: Schoumacher C; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France., Derangère V; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; INSERM LNC-UMR1231 Research Center, TIRECS Team, Dijon, France., Gaudillière-Le Dain G; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France., Huppe T; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France., Rageot D; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; INSERM LNC-UMR1231 Research Center, TIRECS Team, Dijon, France., Ilie A; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France., Vienot A; Department of Medical Oncology, CHU Besançon, Besançon, France., Borg C; Department of Medical Oncology, CHU Besançon, Besançon, France., Monnien F; Department of Pathology, CHU Besançon, Besançon, France., Bibeau F; Department of Pathology, CHU Besançon, Besançon, France., Truntzer C; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; INSERM LNC-UMR1231 Research Center, TIRECS Team, Dijon, France., Ghiringhelli F; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; INSERM LNC-UMR1231 Research Center, TIRECS Team, Dijon, France.; Genetic and Immunology Medical Institute, GIMI, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
Publikováno v: Oncoimmunology [Oncoimmunology] 2023 Dec 21; Vol. 13 (1), pp. 2294563. Date of Electronic Publication: 2023 Dec 21 (Print Publication: 2024).
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.
Autor: Derangère V; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France; Genetic and Immunology Medical Institute, Dijon, France., Lecuelle J; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France., Lepage C; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Fédération Francophone de Cancérologie Digestive, Centre de Randomisation Gestion Analyse, EPICAD LNC 1231, France; Service D'Hépato-gastroentérologie et Oncologie Digestive, CHU de Dijon, France., Aoulad-Ben Salem O; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France., Allatessem BM; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France., Ilie A; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France., Bouché O; CHU Robert Debré, Médecine Ambulatoire-Cancérologie, Reims, France., Phelip JM; Service D'Hépatogastro-entérologie - CHU de Saint Etienne - Hôpital Nord, Saint-Etienne, France., Baconnier M; Centre Hospitalier Annecy Genevois Service HGE, Pringy, France., Pezet D; CHU ESTAING, Service de Chirurgie Digestive, Clermont-Ferrand, France., Sebbagh V; Centre Hospitalier de Compiègne, Service Gastro-entérologie et Hépatologie, Compiègne, France., Terrebonne E; Hôpital Haut Lévêque, Service d'HGE, PESSAC, France., Bouard G; Service D'Anatomie et Cytologie Pathologiques, CHU Côte de Nacre, Normandie Université, Caen, France., Jooste V; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Digestive Cancer Registry of Burgundy, Dijon University Hospital, Dijon France., Bouvier AM; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Digestive Cancer Registry of Burgundy, Dijon University Hospital, Dijon France., Molimard C; CHU de Besançon, Service d'anatomie Pathologique, France., Monnien F; CHU de Besançon, Service d'anatomie Pathologique, France., Gonzalez D; Fédération Francophone de Cancérologie Digestive, Centre de Randomisation Gestion Analyse, EPICAD LNC 1231, France., Le Malicot K; Fédération Francophone de Cancérologie Digestive, Centre de Randomisation Gestion Analyse, EPICAD LNC 1231, France., Rageot D; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France., Truntzer C; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France; Genetic and Immunology Medical Institute, Dijon, France., Bibeau F; CHU de Besançon, Service d'anatomie Pathologique, France., Ghiringhelli F; Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France; Genetic and Immunology Medical Institute, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, F-21000 Dijon, France. Electronic address: fghiringhelli@cgfl.fr.
Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Sep; Vol. 172, pp. 221-230. Date of Electronic Publication: 2022 Jul 01.
Zobrazit plný text záznamu
8
Akademický článek
Using a convolutional neural network for classification of squamous and non-squamous non-small cell lung cancer based on diagnostic histopathology HES images.
Autor: Le Page AL; Department of Pathology, Caen University Hospital, Normandy University, Caen, France., Ballot E; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000, Dijon, France., Truntzer C; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000, Dijon, France.; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, 14 rue Paul Gaffarel, 21000, Dijon, France., Derangère V; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000, Dijon, France.; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, 14 rue Paul Gaffarel, 21000, Dijon, France.; University of Burgundy-Franche Comté, Maison de l'université Esplanade Erasme, 21000, Dijon, France.; UMR INSERM 1231, 7 Boulevard Jeanne d'Arc, 21000, Dijon, France., Ilie A; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000, Dijon, France., Rageot D; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000, Dijon, France.; University of Burgundy-Franche Comté, Maison de l'université Esplanade Erasme, 21000, Dijon, France., Bibeau F; Department of Pathology, Caen University Hospital, Normandy University, Caen, France., Ghiringhelli F; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000, Dijon, France. fghiringhelli@cgfl.fr.; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, 14 rue Paul Gaffarel, 21000, Dijon, France. fghiringhelli@cgfl.fr.; University of Burgundy-Franche Comté, Maison de l'université Esplanade Erasme, 21000, Dijon, France. fghiringhelli@cgfl.fr.; UMR INSERM 1231, 7 Boulevard Jeanne d'Arc, 21000, Dijon, France. fghiringhelli@cgfl.fr.; Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000, Dijon, France. fghiringhelli@cgfl.fr.
Publikováno v: Scientific reports [Sci Rep] 2021 Dec 13; Vol. 11 (1), pp. 23912. Date of Electronic Publication: 2021 Dec 13.
Zobrazit plný text záznamu
9
Akademický článek
Follicular helper-T cells restore CD8 + -dependent antitumor immunity and anti-PD-L1/PD-1 efficacy.
Autor: Niogret J; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France., Berger H; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France., Rebe C; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France., Mary R; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France., Ballot E; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France., Truntzer C; Univ Burgundy Franche Comte, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France., Thibaudin M; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France., Derangère V; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France., Hibos C; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France., Hampe L; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France., Rageot D; Univ Burgundy Franche Comte, Dijon, France., Accogli T; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Quebec, Canada., Joubert P; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Quebec, Canada., Routy B; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada., Harker J; National Heart and Lung Institute, Imperial College London, London, UK., Vegran F; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France., Ghiringhelli F; Centre de Recherche INSERM LNC-UMR1231, Dijon, France fghiringhelli@cgfl.fr fanny.chalmin@gmail.com.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Univ Burgundy Franche Comte, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France., Chalmin F; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6).
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje